Vasoplegic Shock Represents a Dominant Hemodynamic Profile of Multisystem Inflammatory Syndrome Following COVID-19 in Children and Adolescents
- PMID: 35357347
- PMCID: PMC9150787
- DOI: 10.1097/PCC.0000000000002954
Vasoplegic Shock Represents a Dominant Hemodynamic Profile of Multisystem Inflammatory Syndrome Following COVID-19 in Children and Adolescents
Abstract
Objectives: The hemodynamic profile of multisystem inflammatory syndrome in children (MIS-C)-related shock remains poorly defined and, therefore, challenging to support with pharmacotherapy in the ICU. We aimed to evaluate the hemodynamic profile and vasoactive medication management used in MIS-C patients presenting to the ICU in shock and provide data from high-fidelity continuous cardiac output monitoring.
Design: Single-center retrospective case-cohort study.
Setting: Pediatric and cardiac ICU in a quaternary-care hospital.
Patients: All patients who met U.S. Centers for Disease Control and Prevention criteria for MIS-C and who were admitted to the ICU between March 2020 and May 2021 required vasoactive support and were placed on continuous cardiac index (CCI) monitoring. Patients requiring extracorporeal life support were excluded.
Interventions: None.
Measurements and main results: Among 52 children with MIS-C presenting in shock and requiring vasoactive support, 14 patients (27%) were placed on CCI monitoring. These 14 patients had hyperdynamic cardiac index (CI) and low indexed systemic vascular resistance (SVRi) in the first 24 hours with normalization of CI and improved SVRi within the subsequent 24 hours.
Conclusions: Further studies are needed to evaluate the difference between the use of vasoconstrictor versus vasodilators in pediatric patients with MIS-C because a phenotype with high CI and low SVRi may be important.
Copyright © 2022 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Conflict of interest statement
Dr. Vogel received support for article research from the NIH (R61HD105593). She disclosed the off-label product use of anakinra for rare hyperinflammatory condition. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Figures

References
-
- Valverde I, Singh Y, Sanchez-de-Toledo J, et al. ; AEPC COVID-19 Rapid Response Team*: Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation 2021; 143:21–32 - PubMed
-
- Centers for Disease Control and Prevention: CDC Health Alert Network. Emergency Preparedness and Response: Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease 2019 (COVID-19). Health Advisory. 2020. Available at: https://emergency.cdc.gov/han/2020/han00432.asp. Accessed September 2, 2021
-
- Gaies MG, Gurney JG, Yen AH, et al. . Vasoactive–inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass*. Pediatr Crit Care Med 2010; 11:234–238 - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous